BIOTRICITY INC. (BTCY)
↓ Download CSV- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Mar 31
In fiscal 2026, BIOTRICITY INC. reported revenue of $16.00M, up 16.0% from the prior year. The company ran a net loss, with a net margin of -15.0% and a gross margin of 80.9%. It held $6.45M in total assets against $39.41M in total liabilities.
Key ratios (FY2026)
80.9%
Gross margin
10.6%
Operating margin
-15.0%
Net margin
+16.0%
Revenue growth (YoY)
| Metric (FY) | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.00M | $13.79M | $12.06M | $9.64M | $7.65M | $3.38M | $1.42M | $398.2K | — | — |
| Cost of Revenue | $3.05M | $3.23M | $3.71M | $4.20M | $3.08M | $2.11M | $932.0K | $338.3K | — | — |
| Gross Profit | $12.95M | $10.56M | $8.36M | $5.44M | $4.57M | $1.27M | $485.8K | $59.9K | — | — |
| Operating Income | $1.69M | -$2.45M | -$8.83M | -$15.41M | -$16.74M | — | — | — | — | — |
| Net Income | -$2.40M | -$8.42M | -$14.09M | -$18.66M | -$29.13M | -$15.49M | -$11.07M | -$8.59M | -$8.62M | -$7.81M |
| EPS (Diluted) | $-0.12 | $-0.56 | $-1.66 | $-2.26 | $-0.67 | $-0.44 | — | — | — | — |
| Total Assets | $6.45M | $5.64M | $5.94M | $6.51M | $16.68M | $4.44M | $2.00M | $490.7K | $929.4K | $473.5K |
| Total Liabilities | $39.41M | $35.66M | $35.92M | $26.36M | $18.82M | $11.27M | $5.00M | $2.27M | $756.2K | $4.86M |
| Shareholders' Equity | -$34.68M | -$32.01M | -$31.47M | -$19.85M | -$2.14M | -$6.83M | -$3.00M | -$1.78M | $173.2K | -$4.38M |
| Cash & Equivalents | $149.8K | $365.1K | $786.1K | $570.5K | $12.07M | $2.20M | $949.8K | $63.6K | $843.6K | $424.9K |
| Operating Cash Flow | -$719.0K | -$2.38M | -$6.69M | -$13.55M | -$15.16M | -$11.08M | -$7.86M | -$5.22M | -$4.87M | -$3.75M |
| Capital Expenditures | — | — | — | — | $29.8K | — | — | — | — | — |
| Shares Outstanding | 28.60M | 26.08M | 9.35M | 8.51M | 49.81M | 36.12M | 32.59M | 31.05M | 23.71M | 18.08M |